Cisplatin micelle formulation HA132
Term · Oncology and biomedicine · MLC-T-ONC-012611
A micelle formulation containing the inorganic platinum agent cisplatin, with potential antineoplastic activity. Upon administration, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and growth inhibition of tumor cells.
| Identifier | MLC-T-ONC-012611 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | cisplatin micelle HA132 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012611",
"term": "Cisplatin micelle formulation HA132",
"field": "Oncology and biomedicine",
"definition": "A micelle formulation containing the inorganic platinum agent cisplatin, with potential antineoplastic activity. Upon administration, cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and growth inhibition of tumor cells.",
"synonyms": [
"cisplatin micelle HA132"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cisplatin-micelle-formulation-ha132/"
}
Record 4,889 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.